Stoke Therapeutics STOK
NASDAQ STOK
$25.88 +0.38 (+1.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Operating Expenses (2018 - 2026)

Updated

Stoke Therapeutics' Operating Expenses was $74.75 million in Q2 2026, up 81.8% from $41.12 million a year earlier and up 25.3% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Operating Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Stoke Therapeutics' Operating Expenses was $250.97 million through Jun 30, 2026, up 57.2% year-over-year; for FY2025, it came in at $205.01 million, up 48.6% from FY2024.

  • Operating Expenses has now increased for seven consecutive years, with a five-year compound annual growth rate of 31.0% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $137.93 million in FY2024 (+11.6%), $123.55 million in FY2023 (+5.8%), $116.76 million in FY2022 (+35.7%) and $86.07 million in FY2021 (+62.3%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses in data going back to Q2 2018.
  • Compared with a year earlier, Operating Expenses has increased for 29 straight quarters, with growth averaging 40.9% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Operating Expenses ranged from 1.6% (Q3 2023) to 81.8% (Q2 2026).
  • Per Business Quant data, STOK's Operating Expenses in the three quarters before Q2 2026 was $59.65 million (Q1 2026), $62.84 million (Q4 2025) and $53.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Stoke Therapeutics 1.59 Bn 421.92 Mn - 74.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.75 Mn
Mar 31, 2026 59.65 Mn
Dec 31, 2025 62.84 Mn
Sep 30, 2025 53.72 Mn
Jun 30, 2025 41.12 Mn
Mar 31, 2025 47.33 Mn
Dec 31, 2024 36.27 Mn
Sep 30, 2024 34.90 Mn
Jun 30, 2024 34.17 Mn
Mar 31, 2024 32.59 Mn
Dec 31, 2023 32.39 Mn
Sep 30, 2023 30.54 Mn
Jun 30, 2023 30.78 Mn
Mar 31, 2023 29.84 Mn
Dec 31, 2022 30.44 Mn
Sep 30, 2022 30.05 Mn
Jun 30, 2022 28.47 Mn
Mar 31, 2022 27.80 Mn
Dec 31, 2021 24.53 Mn
Sep 30, 2021 22.68 Mn
API Access

Stoke Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=STOK&period=max&api_key=YOUR_API_KEY